top of page
Browse by category
Search


Lilly's oral GLP-1 orforglipron consistent with injectable GLP-1 medicines
The topline Phase 3 results from Eli Lilly ACHIEVE-1 study, evaluating the safety and efficacy of orforglipron compared to placebo in...


Structure announces positive results from oral GLP-1 receptor agonist gsbr-1290
Structure Therapeutics has announced positive results from the Phase 1b multiple ascending dose (MAD) study of its highly selective oral...
Browse by tag






bottom of page

